# US 2020/0139103 A1 · Needleless connector with antimicrobial properties

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0139103 A1
- Document ID: US20200139103A1
- Status: Published application
- Kind: A1
- Application number: 16/447,671
- Filed: 2019-06-20
- Published: 2020-05-07
- Earliest claimed: 2018-11-07
- Assignees: ICU Medical, Inc.
- Applicants: Pursuit Vascular, Inc.
- Inventors: Robert J. Ziebol; Matthew David Beilke
- Web page: https://patentgrep.com/patent/US20200139103A1

## CPC

- A61M 39/162: {with antiseptic agent incorporated within the connector}
- A61M 5/001: {Apparatus specially adapted for cleaning or sterilising syringes or needles}
- A61M 5/162: Needle sets, i.e. connections by puncture between reservoir and tube
- A61M 5/30: Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
- A61M 39/20: Closure caps or plugs for connectors or open ends of tubes
- A61M 39/18: Methods or apparatus for making the connection under sterile conditions, i.e. sterile docking
- A61M 2039/0036: {characterised by a septum having particular features, e.g. having venting channels or being made from antimicrobial or self-lubricating elastomer}
- A61M 2039/0205: {for injecting media}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A needleless connector and methods for preventing microbial ingress in medical device connections are disclosed. Various examples provide a needleless connector including a male luer having a recessed distal tip surface containing a water-soluble antimicrobial composition. Further examples include a trap for retaining antimicrobial composition. As the needleless connector is inserted into a female connector, a tapered surface distal edge acts to push microorganisms, while the distal tip surface is configured to leave microorganisms undisturbed. After insertion of the needleless connector, microorganisms present on the female luer surface are biased to reside in the recess region. The recess, trap, and antimicrobial composition are configured to facilitate a long-lasting supply of antimicrobial solution within the fluid-filled recess, at the same time confining the antimicrobial solution inside the recess. This produces a high concentration of antimicrobial solution for an extended time, killing microbes, stopping microbial ingress, and preventing infections in patients.

## Claims

### Claim 1

A needleless connector comprising:
a male connector having a male tapered surface, the male connector further including:
i) a distal tip having a distal end;
ii) the distal tip having a recess surface proximal to the distal end, wherein the recess surface is radially inward of a line of taper extending along, and distal of, the male tapered surface at a first taper angle relative to a central longitudinal axis of the male connector; and
iii) a water-soluble antimicrobial composition positioned on the recess surface.

### Claim 2 (depends on 1)

The needleless connector of claim 1, the male connector further comprising a tapered surface distal edge proximal to the distal tip of the male connector, the tapered surface distal edge being at a distalmost end of the male tapered surface.

### Claim 3 (depends on 2)

The needleless connector of claim 2, wherein the tapered surface distal edge is proximal to at least part of a recess defined by the recess surface of the male connector.

### Claim 4 (depends on 2)

The needleless connector of claim 2, wherein the distal tip has a proximal edge abutting the tapered surface distal edge, wherein the tapered surface distal edge has an outer diameter, the proximal edge of the distal tip has an outer diameter, and the outer diameter of the tapered surface distal edge is greater than the outer diameter of the proximal edge of the distal tip.

### Claim 5 (depends on 2)

The needleless connector of claim 2, wherein the tapered surface distal edge defines a portion of the recess.

### Claim 6 (depends on 1)

The needleless connector of claim 1, further comprising a fluid flow channel through the male connector.

### Claim 7 (depends on 1)

The needleless connector of claim 1, wherein the antimicrobial composition comprises chlorhexidine.

### Claim 8 (depends on 1)

The needleless connector of claim 1, wherein a plurality of blades extend radially outward from the recess surface.

### Claim 9 (depends on 8)

The needleless connector of claim 8, wherein the plurality of blades have a plurality of blade surfaces.

### Claim 10 (depends on 9)

The needleless connector of claim 9, wherein the blade surfaces contain at least a portion of the water-soluble antimicrobial composition.

### Claim 11 (depends on 8)

The needleless connector of claim 8, wherein the blades are arranged substantially parallel to the central longitudinal axis.

### Claim 12 (depends on 1)

The needleless connector of claim 1, wherein the first taper angle is equal to a second taper angle of the recess surface relative to the central longitudinal axis.

### Claim 13 (depends on 1)

The needleless connector of claim 1, wherein the distal tip defines a recess, the device further comprising a proximal trap comprising a cavity at least partially opening into the recess.

### Claim 14 (depends on 13)

The needleless connector of claim 13, wherein at least a portion of the water-soluble antimicrobial composition is contained within the proximal trap.

### Claim 15

A needleless connector comprising:
a male connector having a male tapered surface configured to engage a female connector, the female connector having a female tapered surface, such that the male tapered surface engages the female tapered surface to form a fluid-tight seal, the male connector further including:
i) a conical taper defined in part by the male tapered surface;
ii) a distal tip having a recess surface proximal to a distal end of the male connector, the recess surface residing inside the conical taper;
iii) a tapered surface distal edge proximal to the distal tip, the tapered surface distal edge having an outer diameter greater than the outer diameter of the distal tip;
iv) a fluid flow channel through the male connector; and
v) a water-soluble antimicrobial composition positioned on the recess surface;
wherein upon insertion of the male connector into the female connector, an annular cavity is formed between the recess surface and the female tapered surface of the female connector.

### Claim 16 (depends on 15)

The needleless connector of claim 15, wherein the device is configured such that the annular cavity defines an annular volume between the male connector and the female connector, and wherein a portion of the antimicrobial composition is dissolvable into a fluid to form a chlorhexidine precipitate on a portion of the female tapered surface.

### Claim 17 (depends on 15)

The needleless connector of claim 15, wherein a plurality of blades extend radially outward from the recess surface into the annular cavity to at least partially divide the annular cavity.

### Claim 18

A needleless connector for delivering an antimicrobial composition into an infusion device, the device comprising:
a male connector having a male tapered surface configured to insert into a female connector of an infusion device, the female connector having a female tapered surface, such that the male tapered surface engages the female tapered surface to form a fluid-tight seal, the male connector having:
i) a conical taper defined in part by the male tapered surface;
ii) a distal tip having an outer diameter that is less than 95 percent of an inner diameter of the female tapered surface at a point radially outward of the distal tip;
iii) a recess surface proximal to the distal tip and inside the conical taper;
iv) a fluid flow channel through the male connector;
v) a water-soluble antimicrobial composition positioned on the recess surface;
wherein, upon insertion of the male connector into the female connector, an annular cavity is formed between the recess surface and the female tapered surface of the female connector, the annular cavity having a proximal end and a distal end, a volume between the proximal end and the distal end, a width measured radially, and a length measured axially;
wherein the male tapered surface has a distal edge that at least partially defines the proximal end of the annular cavity, the distal end of the annular cavity is in fluid communication with a fluid lumen of the infusion device, and the width of the annular cavity is less than 50 percent of the length of the annular cavity; and
wherein a fluid inside the infusion device at least partially fills the annular cavity, and at least a portion of the antimicrobial composition is dispersed within the fluid in the annular cavity.

### Claim 19 (depends on 18)

The needleless connector of claim 18, wherein the distal tip defines a recess, the device further comprising a proximal trap comprising a cavity at least partially opening into the recess.

### Claim 20 (depends on 18)

The needleless connector of claim 18, wherein a plurality of blades extend radially outward from the recess surface into the annular cavity to at least partially divide the annular cavity.
